Ready, Set, Go: The Last Sprint for the EU HTAR

Speaker(s)

Anne Willemsen, MSc, Dutch National Healthcare Institute, Diemen, Netherlands, Roisin Adams, MPharm, MSc., PhD, National Centre for Pharmacoeconomics, Dublin, Ireland & Discipline of Pharmacology and Therapeutics, Trinity College Dublin, Dublin, Ireland, Vanessa Schaub, PhD, Global Access Evidence, F. Hoffmann-La Roche Ltd, Basel, Switzerland, Michal Stanak, Dr.phil, AKC, National Institute for Value and Technologies in Healthcare (NIH), Bratislava, Slovakia and Valentina Strammiello, MA, BA, European Patients’ Forum, Brussels, Belgium

Welcome & ISPOR President’s Address
Eberechukwu Onukwugha
Professor
University of Maryland, Baltimore

Avedis Donabedian Lifetime Achievement Award Presentation
Awardee: C. Daniel Mullins, PhD

Plenary Panel

With only a few more months before the start of the EU HTAR in January 2025, everyone is in full speed ahead towards successful implementation in all organizations. The HTA Coordination Group, it’s subgroups and the European Commission are working hard to finalize all documents, guidances and implementing acts required for a well-functioning system. The session will explore if we are advanced enough and if we are ready for the HTAR to be applied. The session will specifically address how the stakeholders are preparing for the HTAR in their organizations and how they are implementing changes, as well as what key challenges are still ahead. These challenges will differ between the stakeholders. How is industry preparing for the high number of PICO and related analysis they see coming and is AI part of this adaptation? How are HTA bodies getting ready, specifically in Eastern EU countries, the late-access countries, how do they anticipate the usability of the JCA? How are patients and patient organizations preparing and what factors impact a sustainable future for patient input under the HTAR? Lastly, the panel will explore how the HTAR links to already existing regional initiatives, e.g Beneluxa as well as the International Horizon Scanning Initiative (IHSI). Are they mutually beneficial to each other, and how can we leverage the benefits of these collaboratives under the HTAR?

Code

200

Topic

Health Technology Assessment